Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02035852 · ClinicalTrials.gov registry record
High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 184
- Enrollment target
NCT02035852: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT02035852 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 184 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02035852 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 184 participants
- Enrollment target
Study Summary
The study will compare two different size MRI's of a brain tumor.
Primary Outcome
1\. To determine the benefit of 7T MR imaging in brain tumor patients with regard to the improvement in resolution, as measured by the area of T2 FLAIR signal abnormality and the ability to detect abnormalities in vascular integrity. The benefit will be determined at a single time point as well as longitudinally for each patient at 6 month intervals.
Interventions
- OTHER MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2009-08-28 |
| Est. Completion | 2018-04-20 |
What the finished NCT02035852 record still lists
NCT02035852 is an observational study that tracks outcomes without assigning an intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02035852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02035852 about?
NCT02035852 is a clinical study titled "High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors". The study will compare two different size MRI's of a brain tumor.
What is the current status of trial NCT02035852?
This trial is currently completed. The enrollment target is 184 participants. The study started on 2009-08-28. Estimated completion is 2018-04-20.
What interventions are being tested in trial NCT02035852?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT02035852?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI